Cargando…

A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening

Cell-based high-throughput RNAi screening has become a powerful research tool in addressing a variety of biological questions. In RNAi screening, one of the most commonly applied assay system is measuring the fitness of cells that is usually quantified using fluorescence, luminescence and absorption...

Descripción completa

Detalles Bibliográficos
Autores principales: Gilbert, Daniel F., Erdmann, Gerrit, Zhang, Xian, Fritzsche, Anja, Demir, Kubilay, Jaedicke, Andreas, Muehlenberg, Katja, Wanker, Erich E., Boutros, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230607/
https://www.ncbi.nlm.nih.gov/pubmed/22162763
http://dx.doi.org/10.1371/journal.pone.0028338
_version_ 1782218079066914816
author Gilbert, Daniel F.
Erdmann, Gerrit
Zhang, Xian
Fritzsche, Anja
Demir, Kubilay
Jaedicke, Andreas
Muehlenberg, Katja
Wanker, Erich E.
Boutros, Michael
author_facet Gilbert, Daniel F.
Erdmann, Gerrit
Zhang, Xian
Fritzsche, Anja
Demir, Kubilay
Jaedicke, Andreas
Muehlenberg, Katja
Wanker, Erich E.
Boutros, Michael
author_sort Gilbert, Daniel F.
collection PubMed
description Cell-based high-throughput RNAi screening has become a powerful research tool in addressing a variety of biological questions. In RNAi screening, one of the most commonly applied assay system is measuring the fitness of cells that is usually quantified using fluorescence, luminescence and absorption-based readouts. These methods, typically implemented and scaled to large-scale screening format, however often only yield limited information on the cell fitness phenotype due to evaluation of a single and indirect physiological indicator. To address this problem, we have established a cell fitness multiplexing assay which combines a biochemical approach and two fluorescence-based assaying methods. We applied this assay in a large-scale RNAi screening experiment with siRNA pools targeting the human kinome in different modified HEK293 cell lines. Subsequent analysis of ranked fitness phenotypes assessed by the different assaying methods revealed average phenotype intersections of 50.7±2.3%–58.7±14.4% when two indicators were combined and 40–48% when a third indicator was taken into account. From these observations we conclude that combination of multiple fitness measures may decrease false-positive rates and increases confidence for hit selection. Our robust experimental and analytical method improves the classical approach in terms of time, data comprehensiveness and cost.
format Online
Article
Text
id pubmed-3230607
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-32306072011-12-08 A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening Gilbert, Daniel F. Erdmann, Gerrit Zhang, Xian Fritzsche, Anja Demir, Kubilay Jaedicke, Andreas Muehlenberg, Katja Wanker, Erich E. Boutros, Michael PLoS One Research Article Cell-based high-throughput RNAi screening has become a powerful research tool in addressing a variety of biological questions. In RNAi screening, one of the most commonly applied assay system is measuring the fitness of cells that is usually quantified using fluorescence, luminescence and absorption-based readouts. These methods, typically implemented and scaled to large-scale screening format, however often only yield limited information on the cell fitness phenotype due to evaluation of a single and indirect physiological indicator. To address this problem, we have established a cell fitness multiplexing assay which combines a biochemical approach and two fluorescence-based assaying methods. We applied this assay in a large-scale RNAi screening experiment with siRNA pools targeting the human kinome in different modified HEK293 cell lines. Subsequent analysis of ranked fitness phenotypes assessed by the different assaying methods revealed average phenotype intersections of 50.7±2.3%–58.7±14.4% when two indicators were combined and 40–48% when a third indicator was taken into account. From these observations we conclude that combination of multiple fitness measures may decrease false-positive rates and increases confidence for hit selection. Our robust experimental and analytical method improves the classical approach in terms of time, data comprehensiveness and cost. Public Library of Science 2011-12-05 /pmc/articles/PMC3230607/ /pubmed/22162763 http://dx.doi.org/10.1371/journal.pone.0028338 Text en Gilbert et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Gilbert, Daniel F.
Erdmann, Gerrit
Zhang, Xian
Fritzsche, Anja
Demir, Kubilay
Jaedicke, Andreas
Muehlenberg, Katja
Wanker, Erich E.
Boutros, Michael
A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening
title A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening
title_full A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening
title_fullStr A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening
title_full_unstemmed A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening
title_short A Novel Multiplex Cell Viability Assay for High-Throughput RNAi Screening
title_sort novel multiplex cell viability assay for high-throughput rnai screening
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230607/
https://www.ncbi.nlm.nih.gov/pubmed/22162763
http://dx.doi.org/10.1371/journal.pone.0028338
work_keys_str_mv AT gilbertdanielf anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT erdmanngerrit anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT zhangxian anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT fritzscheanja anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT demirkubilay anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT jaedickeandreas anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT muehlenbergkatja anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT wankereriche anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT boutrosmichael anovelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT gilbertdanielf novelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT erdmanngerrit novelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT zhangxian novelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT fritzscheanja novelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT demirkubilay novelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT jaedickeandreas novelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT muehlenbergkatja novelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT wankereriche novelmultiplexcellviabilityassayforhighthroughputrnaiscreening
AT boutrosmichael novelmultiplexcellviabilityassayforhighthroughputrnaiscreening